Cleared Traditional

K221014 - Effortless Oxygen Conserver System Mode...

K221014 is an FDA 510(k) clearance for Effortless Oxygen Conserver System Mode..., manufactured by Effortless Oxygen, LLC. The device is a Class 2 Anesthesiology device with product code NFB cleared through the Traditional 510(k) pathway after a 195-day FDA review.

K221014 · Effortless Oxygen, LLC · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2022
Decision
195d
Days
Class 2
Risk

K221014 is an FDA 510(k) clearance for the Effortless Oxygen Conserver System Models Effortless Pro and Effortless Mobile. Classified as Conserver, Oxygen (product code NFB), Class II - Special Controls.

Submitted by Effortless Oxygen, LLC (Phoenix, US). The FDA issued a Cleared decision on October 17, 2022 after a review of 195 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5905 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Effortless Oxygen, LLC devices

FDA 510(k) Submission Details - K221014

510(k) Number K221014 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 05, 2022
Decision Date October 17, 2022
Days to Decision 195 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
55d slower than avg
Panel avg: 140d · This submission: 195d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

NFB Device Classification - Class 2, Special Controls

Product Code NFB Conserver, Oxygen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5905
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Consultant

Effortless Oxygen., LLC C/O Promedic, LLC
Paul Dryden

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - NFB Conserver, Oxygen

All 17
Devices cleared under the same product code (NFB) and FDA review panel - the closest regulatory comparables to K221014.
Respond OC Conserving Regulator (130-0800)
K250322 · Responsive Respiratory · Jul 2025
Proxima
K220591 · Dynasthetics, LLC · Dec 2022
Apogee
K200401 · Incoba Ltd D/B/A Dynaris · Nov 2020
Demand Nasal Oxygen Cannula, Modified Demand Nasal Oxygen Cannula
K151506 · Salter Labs · Mar 2016
EOCD
K041568 · Respironics, Inc. · Jul 2004
EASY PULSE II OXYGEN CONSERVER
K032018 · Precision Medical, Inc. · Aug 2003